IDEV Technologies
About:
IDEV Technologies is a medical device company focused on the development of products for endovascular and interventional applications.
Website: http://www.idevmd.com/
Top Investors: RiverVest, Bay City Capital, Heron Capital, PTV Healthcare Capital, Piper Sandler
Description:
IDEV Technologies is an emerging growth medical device company focused on the development of products for endovascular and interventional applications. Currently, IDEV markets SUPERA, a novel self-expanding nitinol stent. Using a patented interwoven design, SUPERA offers improved flexibility, radial strength, and kink and crush resistance compared to other marketed stents. SUPERA is currently approved for use in the treatment of biliary strictures in the US. IDEV is currently enrolling patients in the SUPERB IDE trial to study SUPERA's safety and efficacy when used in the superficial femoral artery (SFA).
$74.1M
Webster, Texas, United States
2006-01-01
sales(AT)idevmd.com
Jeffery J. Sheldon
51-100
2012-03-07
Private
© 2025 bioDAO.ai